Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
European Urology Oncology|February 18, 2020
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM TrialRhonda L Bitting, Patrick Healy, Daniel J George, et al.
Prostate Cancer and Prostatic Diseases|January 10, 2024
Genomic classifiers and prognosis of localized prostate cancer: a systematic reviewMatthew J Boyer, David J Carpenter, Jeffrey R Gingrich, et al.
Annals of Internal Medicine|January 20, 2025
Impact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer : A Systematic ReviewAmir Alishahi Tabriz, Matthew J Boyer, Adelaide M Gordon, et al.
European Urology Oncology|July 6, 2024
Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR TrialTian Zhang, Lauren Howard, Bridget F Koontz, et al.
Journal for Immunotherapy of Cancer|August 28, 2021
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)Russell K Pachynski, Chihiro Morishima, Russell Szmulewitz, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT ExperienceAbhishek A Solanki, Kevin Zheng, Alicia N Skipworth, et al.
Journal for Immunotherapy of Cancer|August 8, 2022
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumorsRachel E Sanborn, Michael J Pishvaian, Margaret K Callahan, et al.
Journal of Hematology & Oncology|May 6, 2017
Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stagesMeng Yang, Umit Topaloglu, W Jeffrey Petty, et al.
Cancer|May 5, 2021
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancerDaniel J George, Susan Halabi, Elisabeth I Heath, et al.
JAMA Network Open|January 16, 2026
Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate CancerPedro C Barata, June K Corrigan, Jennifer La, et al.
Pageof 7